Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis

Genes and Immunity

Volumn 1, Issue 2, 1999, Pages 91-96

  Van Krugten, M V ^a   Huizinga, T W J ^a   Kaijzel, E L ^a   Zanelli, E ^a   Drossaers Bakker, K W ^a   Van De Linde, P ^a   Hazes, J M W ^a   Zwinderman, A H ^a   Breedveld, F C ^a   Verweij, C L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Disease susceptibility; Joint erosions; Rheumatoid arthritis; TNF +489 polymorphism

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE COURSE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; JOINT; MALE; PATHOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JOINTS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033224478     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363632     Document Type: Article

References (48)

1. Silman AJ, MacGregor AJ, Thomson W et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. J Rheumatol 1993; 32: 903-907.
2. Lawrence JS, Valkenburg HA, Bremner JM et al. Rheumatoid factors in families. Ann Rheum Dis 1970; 29: 269-274.
3. Aho K, Koskenvuo M, Tuominen J et al. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986; 13: 899-902.
4. Cornelis F, Faure S, Martinez M et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998; 95: 10746-10750.
5. van Zeben D, Hazes JMW, Zwinderman AH et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Arth Rheum 1991; 34: 822-830.
6. Weyand CM, Goronzy JJ. HLA-DRB1 alleles as severity markers in RA. Bull Rheum Dis 1994; 43: 5-8.
7. Nepom GE, Naylor SL, Sakaguchi AY et al. The Autoimmune Diseases II. Academic Press: San Diego, 1992.
8. Wordsworth P, Bell J. Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis 1991; 50: 343-346.
9. Gregersen PK, Silver J. The shared epitope hypothesis. Arth Rheum 1997; 30: 1205-1213.
10. Campbell RD, Trowsdale J, Raqoussis J. Map of the human major histocompatibility complex. Immunol Today 1993; 14: 349-352.
11. Brennan FM, Maini RN, Feldmann M. TNF alpha - a pivotal role in rheumatoid arthritis. Br J Rheumatol 1992; 31: 293-298.
12. Elliott MJ, Maini RN, Feldmann M et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344: 1105-1110.
13. Jacob CO, Fronek Z, Lewis GD et al. Heritable major histocompatibility complex class II-associated differences in production of TNF a: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 28: 599-606.
14. Bendtzen K, Morling N, Fomgaard A et al. Association between HLA-DR2 and production of tumor necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 1998; 28: 606.
15. Westendorp RG, Langermans JA, Huizinga TW et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-173.
16. Pociot F, Briant L, Jongeneel CV et al. Association of TNF and class II MHC alleles with the secretion of TNF-alpha and TNF-beta by human monoclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-232.
17. Mulcahy B, Waldron-Lynch F, McDermott MF et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996; 59: 676-683.
18. Wu WS, McClain KL. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J Interferon Res 1997; 17: 631-635.
19. Uglialoro AM, Turbay D, Pesavento PA et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-a gene promoter. Tissue Antigens 1998; 52: 359-367.
20. Higuchi T, Seke N, Kamizono S et al. Polymorphism of the 5′-flanking region of the human tumor necrosis (TNF)-a gene in Japanese. Tissue Antigens 1998; 51: 605-612.
21. Wilson AG, de Vries N, Pociot F et al. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-560.
22. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNF alpha promotor region. Immunogenetics 1994; 39: 150-154.
23. Brinkman BM, Kaijzel EL, Huizinga TW et al. Detection of a C-insertion polymorphism within the human tumor necrosis factor alpha (TNFA) gene. Hum Genet 1995; 96: 493.
24. Zimmerman PA, Guderian RH, Nutman ThB. A new TNF A promotor allele identified in South American Blacks. Immunogenetics 1996; 44: 485-486.
25. Kaijzel EL, van Krugten MV, Brinkman BM et al. Functional analysis of a human tumor necrosis factor a promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998; 4: 724-733.
26. Pociot F, D'Alfonso S, Compasso S et al. Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol 1995; 42: 501-504.
27. Wilson AG, Symons JA, McDowell TL et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
28. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399.
29. Brinkman BM, Zuijdeest D, Kaijzel EL et al. Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1996; 46: 32-41.
30. Stuber F, Udalova IA, Book M et al. -308 tumor necrosis factor (TNF) polymorphism is associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1996; 46: 42-50.
31. Wilson AG, de Vries N, van de Putte LB, Duff GW. A tumour necrosis factor alpha polymorphism is not associated with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 601-603.
32. Brinkman BM, Huizinga TW, Kurban SS et al. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 1997; 36: 516-521.
33. Vinasco J, Beraun Y, Nieto A et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997; 49: 74-78.
34. D'Alfonso S, Momigliano Richiardi P. An intragenic polymorphism in the human tumor necrosis factor alpha (TNFA) chain-encoding gene. Immunogenetics 1996; 44: 321-322.
35. Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 1997; 159: 6236-6241.
36. Hajeer AH, Worthington J, Silman AJ, Ollier WE. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1*04-bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum 1996; 39: 1109-1114.
37. D'Alfonso S, Colombo G, della Bella S et al. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 1996; 47: 551-555.
38. Keffer J, Probert L, Cazlaris H et al. Transgenic mice expressing human tumor necrosis factor: a predictive model of arthritis. EMBO J 1991; 10: 4025-4031.
39. Hohler T, Kruger A, Schneider PM et al. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol 1997; 109: 562-565.
40. Conway DJ, Holland MJ, Bayley RL et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun 1997; 65: 1003-1006.
41. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997; 26: 143-146.
42. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classication of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
43. Wolfe F, Kleinhek SM, Cathey MA et al. The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with Rheumatoid arthritis. J Rheumatol 1988; 15: 1480-1488.
44. Hazes JM, Dijkmans BC, Vandenbroucke JP et al. Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum 1990; 33: 173-179.
45. van Zeben D, Hazes JMW, Zwinderman AH et al. The severity of rheumatoid arthritis: a 6-year followup study of younger women with symptoms of recent onset. J Rheumatol 1994; 21: 1620-1625.
46. van der Heijde DM, van Leeuwen MA, van Riel PL et al. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 1995; 22: 1792-1796.
47. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1982.
48. Verduyn W, Doxiadis IIN, Drabbels JJM et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison by serological HLA-DR typing of organ donors in Eurotransplant. Hum Immunol 1993; 35: 59-66.